Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1
- PMID: 34034222
- DOI: 10.1016/j.scr.2021.102403
Generation of two induced pluripotent stem cell lines from a retinitis pigmentosa patient with compound heterozygous mutations in CRB1
Abstract
Two human iPSC lines were generated from dermal fibroblasts derived from a patient with retinitis pigmentosa caused by CRB1 mutation using episomal plasmids containing OCT4, SOX2, LIN28, KLF4, L-MYC and mp53DD. These clonal iPSC lines carry compound heterozygous mutations in CRB1 (c.2555 T > C and c.3014A > T). Both lines expressed pluripotency markers, displayed a normal karyotype and demonstrated the ability to differentiate into the three primary germ layers, as well as retinal organoids.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
Establishment of an induced pluripotent stem cell line from a retinitis pigmentosa patient with compound heterozygous CRB1 mutation.Stem Cell Res. 2018 Aug;31:147-151. doi: 10.1016/j.scr.2018.08.001. Epub 2018 Aug 2. Stem Cell Res. 2018. PMID: 30092450
-
Using inducible lentiviral vectors to generate induced pluripotent stem cell line ZOCi001-A from peripheral blood cells of a patient with CRB1-/- retinitis pigmentosa.Stem Cell Res. 2020 May;45:101817. doi: 10.1016/j.scr.2020.101817. Epub 2020 Apr 30. Stem Cell Res. 2020. PMID: 32387899
-
Derivation of two induced pluripotent stem cell lines from a healthy control subject.Stem Cell Res. 2025 Feb;82:103621. doi: 10.1016/j.scr.2024.103621. Epub 2024 Dec 3. Stem Cell Res. 2025. PMID: 39642595
-
Generation of an induced pluripotent stem cell line from a patient with retinitis pigmentosa caused by RP1 mutation.Stem Cell Res. 2019 May;37:101452. doi: 10.1016/j.scr.2019.101452. Epub 2019 Apr 25. Stem Cell Res. 2019. PMID: 31059986
-
Generation of a human iPSC line (BTHBIOi001-A) from a retinitis pigmentosa patient with CNGA1 gene mutation.Stem Cell Res. 2025 Sep;87:103798. doi: 10.1016/j.scr.2025.103798. Epub 2025 Aug 6. Stem Cell Res. 2025. PMID: 40795580
Cited by
-
Stem cell transplantation as a progressing treatment for retinitis pigmentosa.Cell Tissue Res. 2022 Feb;387(2):177-205. doi: 10.1007/s00441-021-03551-3. Epub 2022 Jan 10. Cell Tissue Res. 2022. PMID: 35001210 Review.
-
A review of the 661W cell line as a tool to facilitate treatment development for retinal diseases.Cell Biosci. 2025 Apr 1;15(1):41. doi: 10.1186/s13578-025-01381-2. Cell Biosci. 2025. PMID: 40170180 Free PMC article. Review.
-
Retinal Organoids from Induced Pluripotent Stem Cells of Patients with Inherited Retinal Diseases: A Systematic Review.Stem Cell Rev Rep. 2025 Jan;21(1):167-197. doi: 10.1007/s12015-024-10802-7. Epub 2024 Oct 18. Stem Cell Rev Rep. 2025. PMID: 39422807 Free PMC article.
-
Diverse functions and pathogenetic role of Crumbs in retinopathy.Cell Commun Signal. 2024 May 27;22(1):290. doi: 10.1186/s12964-024-01673-z. Cell Commun Signal. 2024. PMID: 38802833 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials